| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1155/2016/1946585 |
| P8608 | Fatcat ID | release_r44ssdxnung4zdeohydidl63m4 |
| P3181 | OpenCitations bibliographic resource ID | 3433556 |
| P932 | PMC publication ID | 5048043 |
| P698 | PubMed publication ID | 27725934 |
| P50 | author | Senthilkumar Kalimuthu | Q88527085 |
| Prakash Gangadaran | Q57563841 | ||
| Byeong-Cheol Ahn | Q48359162 | ||
| P2093 | author name string | Ho Won Lee | |
| P2860 | cites work | Molecular Imaging | Q22065366 |
| Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells | Q59078526 | ||
| Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors | Q72657549 | ||
| Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response | Q77320555 | ||
| Cancer immunotherapy | Q80066933 | ||
| Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. | Q83214267 | ||
| PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments | Q85364555 | ||
| Combined Fluorescence and Magnetic Resonance Imaging of Primary Macrophage Migration to Sites of Acute Inflammation Using Near-Infrared Fluorescent Magnetic Nanoparticles | Q86705496 | ||
| Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. | Q51905131 | ||
| SYNERGISTIC PROLIFERATION AND ACTIVATION OF NATURAL KILLER CELLS BY INTERLEUKIN 12 AND INTERLEUKIN 18 | Q57194396 | ||
| Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state | Q57779701 | ||
| Molecular imaging in drug development | Q22122025 | ||
| Pathogenesis of systemic lupus erythematosus | Q24672873 | ||
| Evaluation of in vivo labelled dendritic cell migration in cancer patients | Q24799742 | ||
| Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling | Q27340657 | ||
| In vivo imaging and monitoring of transplanted stem cells: clinical applications | Q27693869 | ||
| T cell receptor signaling precedes immunological synapse formation | Q28203073 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| In vivo, multimodal imaging of B cell distribution and response to antibody immunotherapy in mice | Q28752150 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins | Q29547534 | ||
| Functions of natural killer cells | Q29614300 | ||
| The dendritic cell system and its role in immunogenicity | Q29619870 | ||
| Two-photon tissue imaging: seeing the immune system in a fresh light | Q30490456 | ||
| Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model | Q33489877 | ||
| Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. | Q33699321 | ||
| In vivo MRI cell tracking: clinical studies | Q33803809 | ||
| Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages | Q33892422 | ||
| Options for tracking GFP-Labeled transplanted myoblasts using in vivo fluorescence imaging: implications for tracking stem cell fate | Q33898074 | ||
| Regulation of antibody responses via antibodies, complement, and Fc receptors | Q33932750 | ||
| Control of macrophage activation and function by PPARs | Q33962601 | ||
| Complement and its role in innate and adaptive immune responses | Q34088142 | ||
| Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging | Q34164696 | ||
| Cancer vaccines based on dendritic cells loaded with tumor-associated antigens | Q34333552 | ||
| Plasma cells: finding new light at the end of B cell development | Q34450168 | ||
| B cells move to centre stage: novel opportunities for autoimmune disease treatment | Q34544062 | ||
| B lymphocytes: how they develop and function. | Q34813171 | ||
| Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. | Q34838510 | ||
| Functional significance of the perforin/granzyme cell death pathway | Q34931863 | ||
| Understanding immune cell trafficking patterns via in vivo bioluminescence imaging | Q35054695 | ||
| In vivo cell tracking with bioluminescence imaging | Q35162679 | ||
| MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles | Q35196287 | ||
| Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes | Q35605392 | ||
| In vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin | Q35629266 | ||
| To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. | Q35635220 | ||
| Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors | Q39851612 | ||
| Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment | Q40019570 | ||
| Natural killer cells and interferon. | Q40076538 | ||
| In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. | Q40477559 | ||
| In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma. | Q40507101 | ||
| A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging | Q40579830 | ||
| Imaging tri-fusion multimodality reporter gene expression in living subjects | Q40588078 | ||
| Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells | Q40765346 | ||
| Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit | Q40787807 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 | ||
| T cell activation determined by T cell receptor number and tunable thresholds. | Q41186277 | ||
| Trial watch: Dendritic cell-based interventions for cancer therapy | Q42867339 | ||
| Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging | Q43855400 | ||
| Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging | Q44189640 | ||
| Optical imaging of cellular immunotherapy against prostate cancer | Q46178378 | ||
| Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma | Q47308819 | ||
| Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma | Q47372903 | ||
| Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals | Q47413961 | ||
| Superparamagnetic MRI probes for in vivo tracking of dendritic cell migration with a clinical 3 T scanner. | Q48671081 | ||
| Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells | Q35698582 | ||
| Review of functional/anatomical imaging in oncology. | Q35809612 | ||
| Tracking T-cells in vivo with a new nano-sized MRI contrast agent | Q36060729 | ||
| Design of effective immunotherapy for human autoimmunity | Q36148416 | ||
| Natural-killer cells and dendritic cells: "l'union fait la force". | Q36149272 | ||
| Molecular imaging: a new way to study molecular processes in vivo. | Q36358563 | ||
| An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy | Q36437102 | ||
| Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development | Q36539150 | ||
| Molecular imaging of cell-mediated cancer immunotherapy | Q36547964 | ||
| In vivo non invasive molecular imaging for immune cell tracking in small animals | Q36592760 | ||
| Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspective | Q36593192 | ||
| MR imaging of in vivo recruitment of iron oxide-labeled macrophages in experimentally induced soft-tissue infection in mice | Q36600854 | ||
| Assessing responses to cancer therapy using molecular imaging | Q36671088 | ||
| Visualization of the Biological Behavior of Tumor-Associated Macrophages in Living Mice with Colon Cancer Using Multimodal Optical Reporter Gene Imaging | Q36700020 | ||
| NK cells and cancer. | Q36764364 | ||
| Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer | Q36936395 | ||
| Systemic trafficking of macrophages induced by bone cement particles in nude mice | Q36980386 | ||
| Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen | Q37090163 | ||
| Molecular-genetic imaging based on reporter gene expression | Q37181554 | ||
| How B cells shape the immune response against Mycobacterium tuberculosis | Q37383963 | ||
| Controlling natural killer cell responses: integration of signals for activation and inhibition | Q37404156 | ||
| Tracking immune cells in vivo using magnetic resonance imaging | Q37455363 | ||
| Structure and function of immunoglobulins | Q37696721 | ||
| Activating and inhibitory receptors of natural killer cells | Q37766751 | ||
| In vivo imaging of immune cell trafficking in cancer | Q37822291 | ||
| Therapeutic targeting of B cells for rheumatic autoimmune diseases | Q37829817 | ||
| Nanoparticles as computed tomography contrast agents: current status and future perspectives | Q37984484 | ||
| Requisites for successful theranostics with radionuclide-based reporter gene imaging | Q38177892 | ||
| In Vivo Imaging of Natural Killer Cell Trafficking in Tumors | Q38843820 | ||
| Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging. | Q38867979 | ||
| Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT. | Q39113671 | ||
| Dual reporter gene imaging for tracking macrophage migration using the human sodium iodide symporter and an enhanced firefly luciferase in a murine inflammation model | Q39151440 | ||
| In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue | Q39270675 | ||
| Trafficking macrophage migration using reporter gene imaging with human sodium iodide symporter in animal models of inflammation. | Q39655030 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| multimodal imaging | Q66214583 | ||
| biomedical investigative technique | Q66648976 | ||
| P304 | page(s) | 1946585 | |
| P577 | publication date | 2016-09-20 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells | |
| P478 | volume | 2016 |
| Q55004583 | An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles. |
| Q57152800 | Antibody-based tracers for PET/SPECT imaging of chronic inflammatory diseases |
| Q64917058 | Biodistribution and sensitive tracking of immune cells with plasmonic gold nanostars. |
| Q39354519 | Current Perspective on In Vivo Molecular Imaging of Immune Cells. |
| Q37637322 | Current Perspectives on In Vivo Noninvasive Tracking of Extracellular Vesicles with Molecular Imaging. |
| Q41684107 | Molecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies |
| Q41074467 | Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model. |
| Q90323421 | Optical fluorescence imaging with shortwave infrared light emitter nanomaterials for in vivo cell tracking in regenerative medicine |
| Q47899915 | Optimization of Dendritic Cell-Mediated Cytotoxic T-Cell Activation by Tracking of Dendritic Cell Migration Using Reporter Gene Imaging |
| Q92028771 | State of the Art of Natural Killer Cell Imaging: A Systematic Review |
| Q55024747 | Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells. |
| Q64110642 | Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective |
Search more.